Sign in

CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522214851
Phone
617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,244,783
in 2 filings, $3.2M under 10b5-1 plans

Net −$3,244,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tak Paul Peter −$3.2M Chief Executive Officer sold 71% of stake
  2. Tyagarajan Seshu −$84K Chief Technology Officer sold 8% of stake
Date Insider Transaction Shares Price Value Owned after
2023-11-28 Nichols William Garrett Chief Medical Officer Shares withheld for taxes −12,175 $0.90 $11K 135,126
2023-11-28 Tyagarajan Seshu Chief Technology Officer Shares withheld for taxes −17,328 $0.90 $16K 174,230
2023-11-28 Barone Francesca Chief Scientific Officer Shares withheld for taxes −19,748 $0.90 $18K 186,657
2023-11-28 Amello Jason Chief Financial Officer Shares withheld for taxes −20,153 $0.90 $18K 202,009
2023-11-26 Barone Francesca Chief Scientific Officer Grant or award +112,790 206,405
2023-11-26 Nichols William Garrett Chief Medical Officer Grant or award +88,822 147,301
2023-11-26 Tyagarajan Seshu Chief Technology Officer Grant or award +104,516 191,558
2023-11-26 Amello Jason Chief Financial Officer Grant or award +125,717 222,162
2023-11-26 Tak Paul Peter Chief Executive Officer Grant or award +180,108 416,999
2023-06-28 Martell Christopher Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2023-06-28 Gaeta Renee Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2023-06-28 Nguyen Diem Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2023-06-28 Manning Paul B Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2023-06-28 Benz Edward J. JR Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2023-06-28 PAPA JOSEPH C Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2023-06-28 Aguilar-Cordova Estuardo Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2023-06-28 Nabel Gary J. Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2023-06-07 Loggia Nicoletta Director Grant or award · Stock Option (Right to Buy) +28,480 28,480
2023-04-28 Tak Paul Peter Chief Executive Officer Grant or award · Stock Option (Right to Buy) +180,000 180,000
2023-04-28 Tyagarajan Seshu Chief Technology Officer Grant or award · Stock Option (Right to Buy) +90,000 90,000

Page 9 of 13 · 249 trades